Current preservation technology and future prospects of thoracic organs. Part 2: Heart

Current Opinion in Organ Transplantation

Volumn 15, Issue 2, 2010, Pages 156-159

  Jacobs, Steven ^a,b   Rega, Filip ^a,b   Meyns, Bart ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Heart preservation; Heart transplantation; Machine perfusion

Indexed keywords

ELECTROLYTE;

CARDIAC GRAFT REJECTION; CLINICAL STUDY; CRYOPRESERVATION; EUROPE; EXPERIMENTAL DESIGN; FEASIBILITY STUDY; GRAFT SURVIVAL; HEART MACHINE PERFUSION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PRESERVATION; HEART TRANSPLANTATION; LUNG TRANSPLANTATION; REPERFUSION INJURY; REVIEW; UNITED STATES;

ANIMALS; COLD ISCHEMIA; EQUIPMENT DESIGN; HEART TRANSPLANTATION; HUMANS; MYOCARDIAL REPERFUSION INJURY; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PERFUSION; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77952255388     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328337343f     Document Type: Review

References (53)

1. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the international society for heart and lung transplantation: twenty-sixth official adult heart transplant report. J Heart Lung Transplant 2009; 28:1007-1022. This study gives an excellent and detailed overview of the current status in heart transplantation. It also contains a nice comparison between the 1992-2001 cohort and 2002-2008 cohort of cardiac transplantations.
2. Birks EJ, Yacoub MH, Banner NR, Khaghani A. The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol 2004; 19:148-153. (Pubitemid 38373130)
3. Hearse DJ. Cardioplegia. Postgrad Med J 1983; 59:11-24.
4. Landymore R, Murphy JT, Hall R, Islam M. Randomized trial comparing intermittent antegrade warm blood cardioplegia with multidose cold blood cardioplegia for coronary artery bypass. Eur J Cardiothorac Surg 1996; 10:179-184. (Pubitemid 126690713)
5. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995; 46:235-247.
6. Buckberg GD. Invited editorial on effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest'. J Thorac Cardiovasc Surg 1996; 112:1661-1663.
7. Bjornstad H, Lathrop DA, Refsum H. Prevention of some hypothermia induced electromechanical changes by calcium channel blockade. Cardiovasc Res 1994; 28:55-60. (Pubitemid 24060349)
8. Riess ML, Camara AK, Kevin LG, et al. Reduced reactive O2 species formation and preserved mitochondrial NADH and [Ca2+] levels during short-term 17 degrees C ischemia in intact hearts. Cardiovasc Res 2004; 61:580-590.
9. Stowe DF, Fujita S, An J, et al. Modulation of myocardial function and [Ca2+] sensitivity by moderate hypothermia in guinea pig isolated hearts. Am J Physiol 1999;277:H2321-H2332. (Pubitemid 30048153)
10. Drobnis EZ, Crowe LM, Berger T, et al. Cold shock damage is due to lipid phase transitions in cell membranes: a demonstration using sperm as a model. J Exp Zool 1993;265:432-437.
11. Camara AK, Riess ML, Kevin LG, et al. Hypothermia augments reactive oxygen species detected in the guinea pig isolated perfused heart. Am J Physiol Heart Circ Physiol 2004;286:H1289-H1299.
12. 2 formation. FASEB J 2000;14:1953-1964.
13. Salahudeen AK, Huang H, Patel P, Jenkins JK. Mechanism and prevention of cold storage-induced human renal tubular cell injury. Transplantation 2000;70:1424-1431.
14. Rauen U, Kerkweg U, de GH. Iron-dependent vs. iron-independent cold-induced injury to cultured rat hepatocytes: a comparative study in physiological media and organ preservation solutions. Cryobiology 2007;54:77-86. (Pubitemid 46282702)
15. Jahania MS, Sanchez JA, Narayan P, et al. Heart preservation for transplantation: principles and strategies. Ann Thorac Surg 1999;68:1983-1987.
16. Boku N, Tanoue Y, Kajihara N, et al. A comparative study of cardiac preservation with Celsior or University of Wisconsin solution with or without prior administration of cardioplegia. J Heart Lung Transplant 2006;25:219-225. (Pubitemid 43156375)
17. Kajihara N, Morita S, Tanoue Y, et al. The UW solution has greater potential for longer preservation periods than the Celsior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation. Eur J Cardiothorac Surg 2006;29:784-789.
18. Perrault LP, Nickner C, Desjardins N, et al. Improved preservation of coronary endothelial function with Celsior compared with blood and crystalloid solutions in heart transplantation. J Heart Lung Transplant 2001;20:549-558. (Pubitemid 32410016)
19. Chambers DJ, Hearse DJ. Developments in cardioprotection: 'polarized' arrest as an alternative to 'depolarized' arrest. Ann Thorac Surg 1999;68:1960-1966.
20. Snabaitis AK, Shattock MJ, Chambers DJ. Comparison of polarized and depolarized arrest in the isolated rat heart for long-term preservation. Circulation 1997;96:3148-3156.
21. Schubert T, Vetter H, Owen P. Adenosine cardioplegia. Adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart. J Thorac Cardiovasc Surg 1989;98:1057-1065. (Pubitemid 20008601)
22. Jacob M, Paul O, Mehringer L, et al. Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 2009;87:956-965. This preclinical animal study describes the effect on myocardial functioning and endothelial layer of adding 1g% albumin to Custiol compared with Custiol.
23. Rauen U, Klempt S, de GH. Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci 2007;64:192-205. (Pubitemid 46155699)
24. Loganathan S, Radovits T, Hirschberg K, et al. Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury. J Thorac Cardiovasc Surg 2009 [Epub ahead of print]. In this preclinical animal study the effect of lowering the histidine concentration in Custiol and adding an extracellular and intracellular iron chelator was investigated.
25. Cropper JR, Hicks M, Ryan JB, Macdonald PS. Cardioprotection bycariporide after prolonged hypothermic storage of the isolated working rat heart. J Heart Lung Transplant 2003;22:929-936. (Pubitemid 36945493)
26. Kim YI, Herijgers P, Laycock SK, et al. Na+/H+ exchange inhibition improves long-term myocardial preservation. Ann Thorac Surg 1998;66:436-442.
27. Hing AJ, Watson A, Hicks M, et al. Combining cariporide with glyceryl trinitrate optimizes cardiac preservation during porcine heart transplantation. Am J Transplant 2009;9:2048-2056. In this preclinical animal study the Na/H exchange inhibitor Cariporide was added to Celsior. The effect on myocardial function post reperfusion in a porcine heart transplantation model was evaluated.
28. Shimokawa H, Hiramori K, Iinuma H, et al. Antianginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 2002;40:751-761. (Pubitemid 36109293)
29. Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 2002;39:319-327. (Pubitemid 34175055)
30. Kobayashi M, Tanoue Y, Eto M, et al. A Rho-kinase inhibitor improves cardiac function after 24-h heart preservation. J Thorac Cardiovasc Surg 2008;136:1586-1592.
31. Thatte HS, Rousou L, Hussaini BE, et al. Development and evaluation of a novel solution, Somah, for the procurement and preservation of beating and nonbeating donor hearts for transplantation. Circulation 2009;120:1704-1713. In this preclinical animal study a new preservation solution, Somah, is compared with Celsior. The structure and viability of cardiomyocytes and endothelial cells was tested after a 4 h preservation period.
32. Thatte HS, Biswas KS, Najjar SF, et al. Multiphoton microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg 2003;75:1145-1152.
33. Amberger A, Schneeberger S, Hernegger G, et al. Gene expression profiling of prolonged cold ischemia and reperfusion in murine heart transplants. Transplantation 2002;74:1441-1449. (Pubitemid 35379552)
34. Maluf DG, Mas VR, Yanek K, et al. Molecular markers in stored kidneys using perfluorocarbon-based preservation solution: preliminary results. Transplant Proc 2006;38:1243-1246. (Pubitemid 43912759)
35. Zheng X, Lian D, Wong A, et al. Novel small interfering RNA-containing solution protecting donor organs in heart transplantation. Circulation 2009;120:1099-1107. This preclinical animal study describes the effects of silencing genes that play an important role in the inflammation associated with the ischemia/reperfusion injury.
36. Proctor E, Parker R. Preservation of isolated heart for 72 h. Br Med J 1968;4:296-298.
37. Wicomb WN, Novitzky D, Cooper DK, Rose AG. Forty-eight hours hypothermic perfusion storage of pig and baboon hearts. J Surg Res 1986;40:276-284. (Pubitemid 16028093)
38. Wicomb WN, Rose AG, Cooper DK, Novitzky D. Hemodynamic and myocardial histologic and ultrastructural studies on baboons from 3 to 27 months following autotransplantation of hearts stored by hypothermic perfusion for 24 or 48 h. J Heart Transplant 1986;5:122-129. (Pubitemid 17037499)
39. Wicomb WN, Cooper DK, Novitzky D, Barnard CN. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. Ann Thorac Surg 1984;37:243-248. (Pubitemid 14160430)
40. Wicomb WN, Cooper DK, Barnard CN. Twenty-four-hour preservation of the pig heart by a portable hypothermic perfusion system. Transplantation 1982;34:246-250.
41. Wicomb W, Cooper DK, Hassoulas J, et al. Orthotopic transplantation of the baboon heart after 20 to 24 hours' preservation by continuous hypothermic perfusion with an oxygenated hyperosmolar solution. J Thorac Cardiovasc Surg 1982;83:133-140. (Pubitemid 12209562)
42. Wicomb W, Boyd ST, Cooper DK, et al. Ex vivo functional evaluation of pig hearts subjected to 24 hours' preservation by hypothermic perfusion. S Afr Med J 1981;60:245-248. (Pubitemid 11052274)
43. Ho EK, Vlad G, Colovai AI, et al. Alloantibodies in heart transplantation. Hum Immunol 2009;70:825-829. This clinical trial assessed the clinical impact of pre-and post-transplantation allosensitization on long-term survival of heart allografts.
44. Tenderich G, Zittermann A, Prohaska W, Koerfer R. No evidence for an improvement of long-term survival by HLA matching in heart transplant recipients. Transplant Proc 2007;39:1575-1579. (Pubitemid 46907919)
45. McCurry K, Jeevanandam V, Mihaljevic T, et al. Prospective multicenter safety and effectiveness evaluation of the organ care system device for cardiac use (PROCEED). J Heart Lung Transplant 2008;27: S166. (abstract).
46. Tenderich G, El-Banayosy A, Rosengard B, et al. Prospective multicenter European trial to evaluate the safety and performance of the organ care system for heart transplants (PROTECT). J Heart Lung Transplant 2007;26: S64. (abstract).
47. Rosenbaum DH, Peltz M, DiMaio JM, et al. Perfusion preservation versus static preservation for cardiac transplantation: effects on myocardial function and metabolism. J Heart Lung Transplant 2008;27:93-99.
48. Ozeki T, Kwon MH, Gu J, et al. Heart preservation using continuous ex vivo perfusion improves viability and functional recovery. Circ J 2007;71:153-159. (Pubitemid 46045565)
49. Stowe DF, Camara AK, Heisner JS, et al. Low-flow perfusion of guinea pig isolated hearts with 26 degrees C air-saturated Lifor solution for 20 h preserves function and metabolism. J Heart Lung Transplant 2008;27:1008-1015.
50. Hassanein WH, Zellos L, Tyrrell TA, et al. Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function. J Thorac Cardiovasc Surg 1998;116:821-830. (Pubitemid 28499177)
51. Garbade J, Krautz C, Aupperle H, et al. Functional, metabolic, and morpho-logical aspects of continuous, normothermic heart preservation: effects of different preparation and perfusion techniques. Tissue Eng Part C Methods 2009;15:275-283. In this preclinical animal study the effectiveness of two different preservation strategies using continuous, normothermic heart perfusion was compared. Contractility, ATP stores and ultrastructural morphology were assessed.
52. Peltz M, Cobert ML, Rosenbaum DH, et al. Myocardial perfusion characteristics during machine perfusion for heart transplantation. Surgery 2008;144:225-232. (Pubitemid 352010324)
53. Poston RS, Gu J, Prastein D, et al. Optimizing donor heart outcome after prolonged storage with endothelial function analysis and continuous perfusion. Ann Thorac Surg 2004;78:1362-1370. (Pubitemid 39303864)